Frontiers

Frontline Summer 2013 

A Game-Changer

The Personal Cancer Genome and Precision Cancer Trials

By SAMEEK ROYCHOWDHURY, MD, PhD, assistant professor of Internal Medicine and of Pharmacology

Clinical trials traditionally have been designed to treat patients with a specific disease and to treat all patients on the trial the same way. For example, we would evaluate a new drug for breast cancer by giving the agent to a group of breast-cancer patients, and if enough of them benefited, we would judge the drug a good one. If few patients benefited, the drug would likely be abandoned.

During such disease-based trials, a small number of participants, maybe 1-10 percent, can benefit amazingly from the drug, but further development of the agent is unlikely because clinical trials as usually done are impractical for small numbers of patients.

Genomics is now helping us understand why some patients respond differently to therapy; although all the women in our hypothetical trial have cancer of the breast, not all breast cancers are the same.

Traditionally, we diagnose breast cancer, leukemia or prostate cancer by examining the way cells appear under a microscope. This tissue-of-origin approach has provided a histology-based or “microscopic classification” of cancer that has been used for decades.

Histologically, malignancies such as breast and prostate cancer appear to be homogenous. But cancer genomic studies, such as The Cancer Genome Atlas, demonstrate that these cancers are heterogeneous, with sets of mutations and other genetic changes that allow their grouping into subtypes (breast cancer may have more than 25). Each subtype may be a different disease that requires different therapy based on the tumor’s genomics. These molecular subtypes are driving the development of targeted drugs and influencing how we do clinical trials.

For example, a genetic pathway called PI3 kinase (PI3K) is genomically altered or mutated in up to 25 percent of breast cancers, and we have disease- and mutation-based trials such as OSU-12127 evaluating a PI3K inhibitor for breast-cancer patients with a mutation in a PI3K gene. In this trial, a smart drug specifically inhibits the PI3K kinase gene pathway. In contrast, in other cancers, genomic targets are less common, amounting to just 1-10 percent of cases, which effectively turns most cancers into multiple “orphan diseases.”

But how do we complete clinical trials for a gene mutated in only 1 percent of breast cancer or across many different cancers? If a trial needs 100 patients, 10,000 patients must be screened. That’s very challenging; traditional clinical trials are not feasible. Such orphan diseases will require a personalized therapeutic approach, and, consequently, clinical-trial designs are being developed to accommodate this new reality.

Some cancer centers, including the OSUCCC – James, are developing a new type of trial design that “baskets” together different diseases that share a molecular target in one trial (see figure).

In some instances, if we know enough about the molecular subsets of a disease, we may be able to enroll patients into trials that have a drug that matches the molecular makeup of their cancer. To facilitate these trials, cancer centers must be capable of providing a personalized molecular view of an individual’s cancer.

Gene sequencing technology called next-generation sequencing will enable oncologists to determine which of 200-plus significant genes are altered in a patient’s cancer and to use this information to guide therapy. Ohio State is among the leaders in the country in promoting and championing this precision oncology strategy.

In summary, to move forward into the age of precision oncology we need to accomplish four objectives:

1. Complete the molecular characterization of cancer;
2. Develop drugs that target the molecular defects that drive cancer;
3. Implement next-generation sequencing to molecularly characterize the tumors of patients in the clinic;
4. Launch innovative clinical trials that utilize these molecular portraits.

 


 
30-Jul-13
28  Comments  |  Trackback Url  | 0  Link to this post

Bookmark this post with:        
 

Links to this post

Comments


  commented on  Tuesday, September 17, 2013  10:03 PM 


منتديات  commented on  Saturday, December 07, 2013  8:25 AM 
Histologically, malignancies such as breast and prostate cancer appear to be homogenous. But cancer genomic studies, such as The Cancer Genome Atlas, demonstrate that these cancers are heterogeneous, with sets of mutations and other genetic changes that allow their grouping into subtypes (breast cancer may have more than 25). Each subtype may be a different disease that requires different therapy based on the tumor’s genomics. These molecular subtypes are driving the development of targeted drugs and influencing how we do clinical trials.


comedy nights with kapil  commented on  Sunday, September 07, 2014  7:49 AM 
Come on guys i am here to tell you about one of the amazing website that offers you to work through online sources, if you are capable of doing work with us then feel free to contact us for more details.


usamm coupon  commented on  Wednesday, October 08, 2014  7:52 AM 
pretty great post. I simply stumbled upon your weblog and wanted to say that I have really loved browsing your blog posts.


شبكة الرياضيات  commented on  Sunday, October 26, 2014  11:33 AM 
Great thanks for sharing this article post. I was looking for something like this. Your articles have inspires me a lot.Thanks.


bigbangdissertation.com  commented on  Friday, November 07, 2014  2:18 PM 
Life stops when we face some problems in our daily life but it creates more hurdles when your problems are not eradicated with in specific time. If you can remove it then you probably can save money and time. Look at me when i was working online and was writing contents for webmasters but i justified myself and now i have my own company because i came to realize that i have a problem of writing something, i work hard and proved myself as a great worker.


DSF  commented on  Sunday, November 09, 2014  2:30 AM 
http://www.shophandbagsonline.com/
http://www.bestcustomsonline.com/
http://www.nike-jordanshoes.com/
http://www.ralphlaurentshirts.com/
http://www.burberry-factory.com/
http://www.kate-spades.com/
http://www.barbour-factory.com/
http://www.coachlosangeles.com/
http://www.official-coachoutlet.com/
http://www.louisvuittonas.com/
http://www.burberryoutlet2014.com/
http://www.official-mkoutlet.com/
http://www.official-pradaoutlet.com/
http://www.beatsbydreoutlet.net/
http://www.michaelkorsonlineusa.com/
http://www.northsclearance.com/
http://www.abercrombiee.com/
http://www.ralph-laurens.com/
http://www.guccishoes-uk.com/
http://www.michael-korsusa.com/
http://www.polo-outlets.com/
http://www.hermes-outletonline.com/
http://www.ralphslauren.co.uk/
http://www.marcjacobsonsale.com/
http://www.mcmworldwides.com/
http://www.warmbootssale.com/
http://www.salongchamppairs.com/
http://www.canada-gooser.com/
http://www.michaelkors.so/
http://www.oakley-sunglassoutlet.com/
http://www.north-faceoutlets.net/
http://www.moncler-clearance.com/
http://www.woolrich-clearance.com/
http://www.barbour-jacketsoutlet.com/
http://www.moncler-jacketsoutletonline.com/
http://www.monsterbeatsbydres.net/
http://www.lv-guccishoesfactory.com/
http://www.clothes-mall.com/
http://www.coach-factorysoutlet.com/
http://www.coach-blackfriday2014.com/
http://www.coach-clearance.com/
http://www.coach.mischristmas.com/
http://www.coachccoachoutlet.com/
http://www.coach-factories.net/
http://www.coach-pursesoutlets.com/
http://www.coachoutletstates.com/
http://www.zxcoachoutlet.com/
http://www.mischristmas.com/
http://www.misblackfriday.com/
http://www.newoutletonlinemall.com/
http://www.ralphlaurenepolo.com/
http://michaelkorsoutlet.mischristmas.com/
http://mcmbackpack.mischristmas.com/
http://monsterbeats.mischristmas.com/
http://northfaceoutlet.mischristmas.com/
http://mk.misblackfriday.com/
http://coachoutlet.misblackfriday.com/
http://coachfactory.misblackfriday.com/
http://uggaustralia.misblackfriday.com/
http://coachpurses.misblackfriday.com/
http://coachusa.misblackfriday.com/
http://coach.misblackfriday.com/
http://michaelkorss.misblackfriday.com/
http://michaelkors.misblackfriday.com/
http://airmax.misblackfriday.com/
http://michael-kors.misblackfriday.com/
https://twitter.com/CoachOutlet2014
https://www.facebook.com/coachoutletstoreonline
https://www.facebook.com/ralphlaurenoutletonline


psd loft  commented on  Wednesday, November 12, 2014  2:48 AM 
i have a problem of writing something, i work hard and proved myself as a great worker.


psd loft  commented on  Wednesday, November 12, 2014  2:49 AM 
i work hard and proved myself as a great worker


http://www.surfacemag-articles.com  commented on  Saturday, November 15, 2014  1:31 AM 
proved myself as a great worker


this hyperlink  commented on  Saturday, November 15, 2014  2:15 AM 
i work hard and proved myself as a great worker.


Green Smart Living  commented on  Sunday, November 16, 2014  8:03 AM 
the one you mentioned here will be very useful to me! I will post Anine Bing a link to this page on my blog. I am sure my visitors will find that very useful


I found it  commented on  Saturday, November 22, 2014  1:53 AM 
I am sure my visitors will find that very useful


Complete details here  commented on  Wednesday, December 03, 2014  8:32 AM 
Histologically, malignancies such as breast and prostate cancer appear to be homogenous. But cancer genomic studies, such as The Cancer Genome Atlas, demonstrate that these cancers are heterogeneous, with sets of mutations and other genetic changes that allow their grouping into subtypes (breast cancer may have more than 25). Each subtype may be a different disease that requires different therapy based on the tumor’s genomics.


seo services  commented on  Thursday, December 04, 2014  6:25 AM 
for the valuabe information and insights you have so provided here.


Free PDF Links  commented on  Sunday, December 07, 2014  5:12 AM 
ack estrogen and progesterone receptors, and by overexpression of the HER2 receptor. F


water heater review  commented on  Monday, December 08, 2014  8:38 AM 
may not mean much to you, but the insertable measurement just might. You’ll be pleased to know that while this SparXXrX® bullet is small it is mighty as well.


hgh bodybuilding forum  commented on  Thursday, December 11, 2014  1:18 AM 
pleased to know that while this SparXXrX® bullet is small it is mighty as well.


bq maxwell 2 quad core  commented on  Sunday, December 14, 2014  5:42 AM 
pleased to know that while this SparXXrX® bullet is small it is mighty as well.


emotional support animals  commented on  Tuesday, December 16, 2014  4:46 AM 
but they requires monthly fee. I am looking for free one, which can allow visitors chat with us online


Diamond Rings  commented on  Wednesday, December 17, 2014  3:55 AM 
Restructuring of the Statutory Health Insurance (GKV-Versorgungsstrukturgesetz), instead


game of war fire age hack no survey  commented on  Wednesday, December 17, 2014  7:24 AM 
company and were hired as consultants by the British Council to carry on working on their film


study  commented on  Thursday, December 18, 2014  1:30 AM 
here will be very useful to me! I will post Anine Bing a link to this page on my blog. I am sure my visitors will find that very useful


accountancy franchise  commented on  Saturday, December 20, 2014  5:24 AM 
liders is also fully responsive. Every element has been tweaked for different screen sizes to make sure it


malaysian hair  commented on  Saturday, December 20, 2014  6:29 AM 
when i was working online and was writing contents for webmasters but i justified myself and now


gloves touch  commented on  Sunday, December 21, 2014  1:20 AM 
I read blogs at a similar topic, but my partner and i never visited ones blog. my spouse and i additional This in order to favorites AND ALSO i’ll possibly be the constant reader.


Gudang Futsal  commented on  Sunday, December 21, 2014  4:46 AM 
I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts.


https://www.rebelmouse.com/manifestationmiraclereviews/  commented on  Sunday, December 21, 2014  7:31 AM 
This tissue-of-origin approach has provided a histology-based or “microscopic classification” of cancer that has been

Name *:
URL:
Email:
Comments:

CAPTCHA Image Validation